These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 32896889)

  • 41. The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design.
    Agesen RM; Alibegovic AC; Andersen HU; Beck-Nielsen H; Gustenhoff P; Hansen TK; Hedetoft C; Jensen T; Juhl CB; Lerche SS; Nørgaard K; Parving HH; Tarnow L; Thorsteinsson B; Pedersen-Bjergaard U
    BMC Endocr Disord; 2019 Jul; 19(1):78. PubMed ID: 31337371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors associated with quality of life in patients with diabetic hypoglycaemia.
    Huang MC; Hung CH; Chen CY; Hung WW; Liang HL
    J Clin Nurs; 2020 May; 29(9-10):1704-1711. PubMed ID: 31944477
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Mild hypoglycaemia is common in type 2 diabetic patients treated with insulin analogues in the Czech Republic and the patients are concerned about it: results of a GAPP2TM survey (Global Attitudes of Physicians and Patient)].
    Prázný M
    Vnitr Lek; 2015 Mar; 61(3):269-75. PubMed ID: 25873125
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Attitudes and perceptions towards hypoglycaemia in patients with diabetes mellitus: A multinational cross-sectional study.
    Naser AY; Wong ICK; Whittlesea C; Alwafi H; Abuirmeileh A; Alsairafi ZK; Turkistani FM; Bokhari NS; Beykloo MY; Al-Taweel D; Almane MB; Wei L
    PLoS One; 2019; 14(10):e0222275. PubMed ID: 31647820
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HypoAware: development and pilot study of a brief and partly web-based psychoeducational group intervention for adults with Type 1 and insulin-treated Type 2 diabetes and problematic hypoglycaemia.
    Rondags SM; de Wit M; Snoek FJ
    Diabet Med; 2016 Feb; 33(2):184-91. PubMed ID: 26234919
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration.
    UK Hypoglycaemia Study Group
    Diabetologia; 2007 Jun; 50(6):1140-7. PubMed ID: 17415551
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A study to assess the unmet medical needs associated with the use of basal insulin in patients with type 2 diabetes.
    Frechtel G; Forti L; Faingold C; Perez Mangui F; Orio S; Issa C; Guaita MS; Vivas N; De Luca JA
    Endocrinol Diabetes Metab; 2021 Jan; 4(1):e00164. PubMed ID: 33532606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factors associated with nocturnal hypoglycaemia among patients with type 2 diabetes new to insulin therapy: experience with insulin lispro.
    Bastyr EJ; Huang Y; Brunelle RL; Vignati L; Cox DJ; Kotsanos JG
    Diabetes Obes Metab; 2000 Jan; 2(1):39-46. PubMed ID: 11220353
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Incidence of severe hypoglycemia in relation to metabolic control and patient knowledge].
    Ratzmann KP; Schimke E
    Med Klin (Munich); 1995 Oct; 90(10):557-61. PubMed ID: 7500918
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypoglycaemia requiring medical assistance in patients with diabetes: a prospective multicentre survey in tertiary hospitals.
    Liatis S; Mylona M; Kalopita S; Papazafiropoulou A; Karamagkiolis S; Melidonis A; Xilomenos A; Ioannidis I; Kaltsas G; Lanaras L; Papas S; Basagiannis C; Kokkinos A
    Diabetes Metab; 2015 Apr; 41(2):126-31. PubMed ID: 25468446
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impaired Awareness of Hypoglycaemia in Insulin-treated Type 2 Diabetes Mellitus.
    Alkhatatbeh MJ; Abdalqader NA; Alqudah MAY
    Curr Diabetes Rev; 2019; 15(5):407-413. PubMed ID: 30081789
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Socioeconomic factors associated with hypoglycaemia in patients starting second-line glucose-lowering therapy: The DISCOVER study.
    Rathmann W; Charbonnel B; Gomes MB; Hammar N; Khunti K; Kosiborod M; Kuss O; Shestakova MV; Watada H; Shimomura I; Tang F; Cid-Ruzafa J; Chen H; Fenici P; Surmont F; Ji L;
    Diabetes Res Clin Pract; 2020 Jul; 165():108250. PubMed ID: 32531326
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical outcomes in high-hypoglycaemia-risk patients with type 2 diabetes switching to insulin glargine 300 U/mL versus a first-generation basal insulin analogue in the United States : Results from the DELIVER High Risk real-world study.
    Sullivan SD; Freemantle N; Gupta RA; Wu J; Nicholls CJ; Westerbacka J; Bailey TS
    Endocrinol Diabetes Metab; 2022 Jan; 5(1):e00306. PubMed ID: 34807513
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypoglyceamia cases in diabetic patients with insulin and oral hypoglycemic agents: A retrospective research in a secondary health facility.
    Vu TQ
    J Pak Med Assoc; 2019 Jun; 69(Suppl 2)(6):S75-S79. PubMed ID: 31369537
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incidence and severity of hypoglycaemia in type 2 diabetes by treatment regimen: A UK multisite 12-month prospective observational study.
    Dunkley AJ; Fitzpatrick C; Gray LJ; Waheed G; Heller SR; Frier BM; Davies MJ; Khunti K;
    Diabetes Obes Metab; 2019 Jul; 21(7):1585-1595. PubMed ID: 30843327
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lower risk of hypoglycaemia and greater odds for weight loss with initiation of insulin detemir compared with insulin glargine in Turkish patients with type 2 diabetes mellitus: local results of a multinational observational study.
    Damci T; Emral R; Svendsen AL; Balkir T; Vora J;
    BMC Endocr Disord; 2014 Jul; 14():61. PubMed ID: 25048824
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain: 52-week data from the PREDICTIVE study in a cohort of French patients with type 1 or type 2 diabetes.
    Marre M; Pinget M; Gin H; Thivolet C; Hanaire H; Robert JJ; Fontaine P
    Diabetes Metab; 2009 Dec; 35(6):469-75. PubMed ID: 19914118
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Self-Reported Hypoglycemia in Insulin-Treated Patients with Diabetes: Results from the Philippine Cohort of the International Operations Hypoglycemia Assessment Tool (IO HAT) Study.
    Mirasol R; Nicodemus N; Jain A; Gadekar AV; Yu-Gan S
    J ASEAN Fed Endocr Soc; 2018; 33(1):12-21. PubMed ID: 33442106
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypoglycaemia with oral antidiabetic drugs: results from prescription-event monitoring cohorts of rosiglitazone, pioglitazone, nateglinide and repaglinide.
    Vlckova V; Cornelius V; Kasliwal R; Wilton L; Shakir SA
    Drug Saf; 2009; 32(5):409-18. PubMed ID: 19419235
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is all hypoglycaemia treated as equal? An observational study of how the type of diabetes and treatment prescribed prior to admission influences quality of treatment of inpatient hypoglycaemia.
    Jones GC; Khan J; Sainsbury CAR
    Acta Diabetol; 2017 Mar; 54(3):247-250. PubMed ID: 27896444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.